In my last post I discussed reasons why the FDA hasn’t kept us safe from dangerous drugs, either by approving those with questionable safety profiles (t-PA for stroke), or by failing to act when a drug’s widespread use reveals hazardous side-effects (Vioxx for inflammation). Continue reading →